CLINICAL STUDY OF VISCERAL LESIONS AND ENDOCRINE DISTURBANCES IN EIGHT CASES OF DIFFUSE SCLERODERMA

Abstract

Article1 April 1951CLINICAL STUDY OF VISCERAL LESIONS AND ENDOCRINE DISTURBANCES IN EIGHT CASES OF DIFFUSE SCLERODERMAJAVIER ROBLES GILJAVIER ROBLES GILAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-34-4-862 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe visceral lesions of diffuse scleroderma have been described by Weiss,1, 2 Lindsay et al.,3 Talbott et al.,4 Barber,5 Stafne et al.,6 Bevans7 and Mathisen et al.8The existing ignorance regarding the etiology of diffuse scleroderma, as well as of some of its clinical, histologic, radiologic and laboratory aspects, makes it necessary and of great interest to describe new cases, with the results of investigations focused on the problems just mentioned above.The aim of this paper is not only to contribute to the solution of these problems, but also to investigate the endocrine status of patients with diffuse scleroderma,...Bibliography1. Weiss S: Diseases of the heart and the aorta which are not well recognized, M. Clin. North America 23: 1323-1344, 1939. CrossrefGoogle Scholar2. WeissSteadWarrenBailey SEAJVOT: Scleroderma heart disease, Arch. Int. Med. 71: 749-776, 1943. CrossrefGoogle Scholar3. LindsayTempletonRothman FRFES: Lesions of the esophagus in generalized progressive scleroderma, J. A. M. A. 123: 745-750, 1943. CrossrefGoogle Scholar4. TalbottGallConsolazioCoombs JHEAWVFS: Dermatomyositis with focal cortical necrosis, Arch. Int. Med. 63: 476-496, 1939. CrossrefGoogle Scholar5. Barber HW: Scleroderma of buccal mucous membrane, Proc. Roy. Soc. Med. 37: 73, 1944. CrossrefMedlineGoogle Scholar6. StafneAustin ECLT: Characteristic dental findings in acrosclerosis and diffuse scleroderma, Am. J. Orthodontics 30: 25-29, 1944. CrossrefGoogle Scholar7. Bevans M: Pathology of scleroderma with special reference to the changes in the gastro-intestinal tract, Am. J. Path. 21: 25-45, 1945. MedlineGoogle Scholar8. MathisenPalmer AKJD: Diffuse scleroderma with involvement of the heart, Am. Heart J. 33: 366-374, 1947. CrossrefMedlineGoogle Scholar9. Robles GilGuerra JF: Inhibicion por el salicilato de sodio de la difusion cutanea de la hialuronidasa en enfermos reumaticos, Arch. Inst. cardiol. México 17: 733-746, 1947. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Mexico City, Mexico, D. F.*Received for publication December 14, 1949.From the Instituto Nacional de Cardiologia, Mexico. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byProgressive systemische Sklerodermie (Sklerose)SklerodermieCardiovascular SystemOesophageal changes in systemic sclerosis.Systemic scleroderma with complete heart blockDecreased oxidative deamination of catecholamines associated with clinical sclerodermaPathologische Veränderungen an Grundsubstanz, Kollagen und ElasticaVALVULAR DISEASE OF THE HEART IN SYSTEMIC SCLERODERMA.Progressive Systemic Sclerosis of the Intestine Presenting as Malabsorption SyndromeMalabsorption in AcrosclerosisTHE HEART IN SCLERODERMAPrognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic SclerodermaMyokarditis und weitere MyokardiopathienDie Viscerale Manifestation der progressiven SklerodermieThe electrocardiogram in scleroderma: Analysis of 60 cases and review of the literatureElectrocardiograms of Ninety Patients with Acrosclerosis and Progressive Diffuse Sclerosis (Scleroderma)Scleroderma (Acrosclerosis)Clinical and Serological Evaluation of 6162 Comparative Slide Tests with Cardiolipin, Natural Lecithin Antigen and Cardiolipin, Synthetic Lecithin Antigen1Small Intestinal Lesions with Steatorrhea in Diffuse Systemic Sclerosis (Scleroderma)Early Cardiac Connective Tissue Changes in SclerodermaRHEUMATISM AND ARTHRITIS REVIEW OF AMERICAN AND ENGLISH LITERATURE OF RECENT YEARS (ELEVENTH RHEUMATISM REVIEW)* Part IIWILLIAM D. ROBINSON, M.D., F.A.C.P., JOSEPH J. BUNIM, M.D., F.A.C.P., WILLIAM S. CLARK, M.D., DARRELL C. CRAIN, M.D., F.A.C.P., EPHRAIM P. ENGLEMAN, M.D., F.A.C.P., DONALD C. GRAHAM, M.D., F.R.C.P. (C), MAX M. MONTGOMERY, M.D., F.A.C.P., BERNARD M. NORCROSS, M.D., F.A.C.P., CHARLES RAGAN, M.D., F.A.C.P., MARIAN W. ROPES, M.D., F.A.C.P., EDWARD F. ROSENBERG, M.D., F.A.C.P., CHARLEY J. SMYTH, M.D., F.A.C.P.Die progressive SklerodermieCollagen DiseasesOSTEOMALACIA IN NEW YORK*I. SNAPPER, M.D., R. SEELY, M.D., S. FALK, M.D., I. FEDER, M.D., F.A.C.P.SCLERODERMA: RELATION OF PULMONARY CHANGES TO ESOPHAGEAL DISEASE*PETER R. MAHRER, M.D., JOHN A. EVANS, M.D., ISRAEL STEINBERG, M.D., F.A.C.P.Progressive Systemic Sclerosis (Scleroderma)Discussion on Scleroderma 1 April 1951Volume 34, Issue 4Page: 862-871KeywordsEtiologyLesionsResearch laboratoriesScleroderma ePublished: 1 December 2008 Issue Published: 1 April 1951 PDF downloadLoading ...